Yamauchi Rie, Ohno Shuji, Obata Yasuko
Division of Pharmaceutical Education and Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Laboratory of Pharmaceutical Science and Technology, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Pharmaceutics. 2025 May 21;17(5):677. doi: 10.3390/pharmaceutics17050677.
: Reverse iontophoresis (R-IP) is a technology that transdermally delivers components from inside the body to outside the body using electroosmotic flow (EOF) generated by applying a low electric current through the skin. It has attracted attention as a non-invasive sampling method for therapeutic drug monitoring (TDM). The purpose of this study was to determine whether urea and Tween 80 effectively enhance drug extraction from beneath the skin using R-IP. : An in vitro drug extraction test using hairless mouse skin and R-IP was performed with a 3-chamber Franz cell and Ag|AgCl electrodes by applying a constant current (0.25 mA/cm) for 6 h. Acetaminophen was chosen as the model drug, and its solution (30, 100, or 300 μg/mL) was placed in the subdermal compartment. The pH of both the electrode and subdermal compartment solutions was maintained at 7.4. : Acetaminophen was gradually extracted into the electrode compartment in a concentration-dependent manner and was more abundant in the cathode compartment than in the anode compartment. In addition, urea significantly promoted drug extraction, particularly on the cathode side, and a linear relationship was observed between the subdermal concentration and extracted amount. This effect is likely due to skin hydration caused by urea, which enhances EOF generation in the skin. Conversely, Tween 80 had no effect on drug extraction. : R-IP combined with urea is expected to not only shorten the treatment time but also enable its application to drugs with low concentrations in blood.
反向离子电渗疗法(R-IP)是一种利用通过皮肤施加低电流产生的电渗流(EOF)将体内成分经皮输送到体外的技术。作为一种用于治疗药物监测(TDM)的非侵入性采样方法,它已引起关注。本研究的目的是确定尿素和吐温80是否能有效增强使用R-IP从皮下提取药物的能力。
使用无毛小鼠皮肤和R-IP进行体外药物提取试验,采用三室Franz扩散池和Ag|AgCl电极,施加恒定电流(0.25 mA/cm)6小时。选择对乙酰氨基酚作为模型药物,将其溶液(30、100或300 μg/mL)置于皮下腔室。电极和皮下腔室溶液的pH均维持在7.4。
对乙酰氨基酚以浓度依赖的方式逐渐提取到电极腔室中,且在阴极腔室中的含量比阳极腔室中更多。此外,尿素显著促进了药物提取,尤其是在阴极侧,并且在皮下浓度和提取量之间观察到线性关系。这种效应可能是由于尿素引起的皮肤水合作用,从而增强了皮肤中EOF的产生。相反,吐温80对药物提取没有影响。
R-IP与尿素相结合不仅有望缩短治疗时间,还能使其应用于血液中低浓度的药物。